Xencor (XNCR) Operating Expenses (2013 - 2026)
Xencor's (XNCR) quarterly Operating Expenses came in at $82.4 million in Q1 2026, up 8.51% year-on-year from $75.9 million in Q1 2025, and up 0.63% on a QoQ basis from $81.9 million in Q4 2025.
Xencor (XNCR) Operating Expenses (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 14 years of Operating Expenses data on file, last reported at $82.4 million in Q1 2026.
- On a quarterly basis, Operating Expenses rose 8.51% year-over-year to $82.4 million in Q1 2026; TTM through Mar 2026 was $309.5 million, a 5.23% increase from a year earlier, with the FY2025 full-year figure at $303.1 million, up 4.91% from the prior year.
- Operating Expenses for Q1 2026 stood at $82.4 million, up from $81.9 million in the prior quarter.
- Over the last five years, Operating Expenses for XNCR reached as high as $82.4 million in Q1 2026 and fell as low as $58.2 million in Q2 2022.
- Historically, Operating Expenses has averaged $72.3 million across 5 years, with a median of $73.0 million in 2024.
- Across the five-year window, Operating Expenses jumped 32.69% in 2023 and fell 17.22% in 2024, its largest moves.
- Year by year, Operating Expenses stood at $64.2 million in 2022, then advanced by 24.13% to $79.7 million in 2023, then decreased by 17.22% to $66.0 million in 2024, then rose by 24.09% to $81.9 million in 2025, then advanced by 0.63% to $82.4 million in 2026.
- Per Business Quant data, the three most recent Operating Expenses figures were $82.4 million in Q1 2026, $81.9 million in Q4 2025, and $68.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.10 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -919.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 445.22 Mn |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - | 82.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 82.38 Mn |
| Dec 31, 2025 | 81.87 Mn |
| Sep 30, 2025 | 68.52 Mn |
| Jun 30, 2025 | 76.78 Mn |
| Mar 31, 2025 | 75.92 Mn |
| Dec 31, 2024 | 65.97 Mn |
| Sep 30, 2024 | 72.99 Mn |
| Jun 30, 2024 | 79.28 Mn |
| Mar 31, 2024 | 70.66 Mn |
| Dec 31, 2023 | 79.70 Mn |
| Sep 30, 2023 | 77.43 Mn |
| Jun 30, 2023 | 71.52 Mn |
| Mar 31, 2023 | 78.33 Mn |
| Dec 31, 2022 | 64.20 Mn |
| Sep 30, 2022 | 65.65 Mn |
| Jun 30, 2022 | 58.18 Mn |
| Mar 31, 2022 | 59.03 Mn |
| Dec 31, 2021 | 62.36 Mn |
| Sep 30, 2021 | 60.98 Mn |
| Jun 30, 2021 | 58.36 Mn |